SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Chunyi Xue, Guobin Tian, Xianxian Chen, Qiliang Liu, Jun Ma, Shun Xu, Xiaoming Li, Hualan Chen, Yongchang Cao, Incorporation of conserved nucleoprotein into influenza virus-like particles could provoke a broad protective immune response in BALB/c mice and chickens, Virus Research, 2015, 195, 35

    CrossRef

  2. 2
    Ramaiah Arunachalam, Adaptive evolution of a novel avian-origin influenza A/H7N9 virus, Genomics, 2014, 104, 6, 545

    CrossRef

  3. 3
    Svetlana Shcherbik, Sheila B. Sergent, William G. Davis, Bo Shu, John Barnes, Irina Kiseleva, Natalie Larionova, Alexander Klimov, Tatiana Bousse, Application of real time RT-PCR for the genetic homogeneity and stability tests of the seed candidates for live attenuated influenza vaccine production, Journal of Virological Methods, 2014, 195, 18

    CrossRef

  4. 4
    C. A. Corzo, M. Allerson, M. Gramer, R. B. Morrison, M. Torremorell, Detection of Airborne Influenza A Virus in Experimentally Infected Pigs With Maternally Derived Antibodies, Transboundary and Emerging Diseases, 2014, 61, 1
  5. 5
    Huiling Wei, Stephen D. Lenz, David H. Thompson, Roman M. Pogranichniy, DNA-Epitope Vaccine Provided Efficient Protection to Mice Against Lethal Dose of Influenza A Virus H1N1, Viral Immunology, 2014, 27, 1, 14

    CrossRef

  6. 6
    Ryuta Uraki, Subash C. Das, Masato Hatta, Maki Kiso, Kiyoko Iwatsuki-Horimoto, Makoto Ozawa, Cevayir Coban, Ken J. Ishii, Yoshihiro Kawaoka, Hemozoin as a novel adjuvant for inactivated whole virion influenza vaccine, Vaccine, 2014, 32, 41, 5295

    CrossRef

  7. 7
    Motoyasu Onishi, Mitsutaka Kitano, Keiichi Taniguchi, Tomoyuki Homma, Masanori Kobayashi, Akihiko Sato, Cevayir Coban, Ken J. Ishii, Hemozoin is a potent adjuvant for hemagglutinin split vaccine without pyrogenicity in ferrets, Vaccine, 2014, 32, 25, 3004

    CrossRef

  8. 8
    C. Keijzer, B.J. Haijema, T. Meijerhof, P. Voorn, A. de Haan, K. Leenhouts, M.L. van Roosmalen, W. van Eden, F. Broere, Inactivated influenza vaccine adjuvanted with Bacterium-like particles induce systemic and mucosal influenza A virus specific T-cell and B-cell responses after nasal administration in a TLR2 dependent fashion, Vaccine, 2014, 32, 24, 2904

    CrossRef

  9. 9
    Siying Ye, Justin G. Evans, John Stambas, Influenza reverse genetics: dissecting immunity and pathogenesis, Expert Reviews in Molecular Medicine, 2014, 16,

    CrossRef

  10. 10
    Laëtitia Minodier, Thierry Blanchon, Cecile Souty, Clement Turbelin, Frederic Leccia, Laurent Varesi, Alessandra Falchi, Influenza vaccine effectiveness: best practice and current limitations of the screening method and their implications for the clinic, Expert Review of Vaccines, 2014, 13, 8, 1039

    CrossRef

  11. 11
    A. Morokutti, T. Muster, B. Ferko, Intranasal vaccination with a replication-deficient influenza virus induces heterosubtypic neutralising mucosal IgA antibodies in humans, Vaccine, 2014, 32, 17, 1897

    CrossRef

  12. 12
    Jung-Min Yeo, Hyun-Jeong Lee, Jae-Won Kim, Joong-Bok Lee, Seung-Yong Park, In-Soo Choi, Chang-Seon Song, Lactobacillus fermentum CJL-112 protects mice against influenza virus infection by activating T-helper 1 and eliciting a protective immune response, International Immunopharmacology, 2014, 18, 1, 50

    CrossRef

  13. 13
    M. Pomorska-Mól, K. Kwit, I. Markowska-Daniel, C. Kowalski, Z. Pejsak, Local and systemic immune response in pigs during subclinical and clinical swine influenza infection, Research in Veterinary Science, 2014, 97, 2, 412

    CrossRef

  14. 14
    Carolien E. van de Sandt, Joost H.C.M. Kreijtz, Martina M. Geelhoed-Mieras, Stella E. Vogelzang-van Trierum, Nella J. Nieuwkoop, David A.M.C. van de Vijver, Ron A.M. Fouchier, Albert D.M.E. Osterhaus, Bror Morein, Guus F. Rimmelzwaan, Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine, Vaccine, 2014, 32, 43, 5614

    CrossRef

  15. 15
    Goeun Lee, Yun Jeong Na, Bo-Gie Yang, Jun-Pyo Choi, Yong Bok Seo, Chun-Pyo Hong, Chang Ho Yun, Dae Heon Kim, Eun Ju Sohn, Jeong Hee Kim, Young Chul Sung, Yoon-Keun Kim, Myoung Ho Jang, Inhwan Hwang, Oral immunization of haemaggulutinin H5 expressed in plant endoplasmic reticulum with adjuvant saponin protects mice against highly pathogenic avian influenza A virus infection, Plant Biotechnology Journal, 2014, 12, 9
  16. 16
    Hyun-Mi Pyo, Yan Zhou, Protective efficacy of intranasally administered bivalent live influenza vaccine and immunological mechanisms underlying the protection, Vaccine, 2014, 32, 30, 3835

    CrossRef

  17. 17
    Solmaz Dehghan, Mohsen Tafaghodi, Tina Bolourieh, Vahideh Mazaheri, Ali Torabi, Khalil Abnous, Masoumeh Tavassoti Kheiri, Rabbit nasal immunization against influenza by dry-powder form of chitosan nanospheres encapsulated with influenza whole virus and adjuvants, International Journal of Pharmaceutics, 2014, 475, 1-2, 1

    CrossRef

  18. 18
    Yu-Na Lee, Hye Suk Hwang, Min-Chul Kim, Young-Tae Lee, Jong Seok Lee, Martin L. Moore, Sang-Moo Kang, Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV disease, Antiviral Research, 2014,

    CrossRef

  19. 19
    Olga V. Chervyakova, Vitaliy M. Strochkov, Elmira T. Tailakova, Kulyaisan T. Sultankulova, Nurlan T. Sandybayev, Abylay R. Sansyzbay, Nikolay E. Gorev, Maria V. Sergeeva, Marina V. Potapchuk, Irina A. Repko, Ludmila M. Tsybalova, Oleg I. Kiselev, Recombinant Strain A/HK/Otar/6:2/2010 (H3N8) for Development of a Live Intranasal Equine Influenza Vaccine, Journal of Equine Veterinary Science, 2014, 34, 6, 749

    CrossRef

  20. 20
    Tian Jiang, Scott D. Kennedy, Walter N. Moss, Elzbieta Kierzek, Douglas H. Turner, Secondary Structure of a Conserved Domain in an Intron of Influenza A M1 mRNA, Biochemistry, 2014, 53, 32, 5236

    CrossRef

  21. 21
    Rohan S. Ingrole, Wenqian Tao, Jatindra N. Tripathy, Harvinder S. Gill, Synthesis and Immunogenicity Assessment of Elastin-Like Polypeptide-M2e Construct as an Influenza Antigen, Nano LIFE, 2014, 04, 02, 1450004

    CrossRef

  22. 22
    Agnieszka Rynda-Apple, Dustin P Patterson, Trevor Douglas, Virus-like particles as antigenic nanomaterials for inducing protective immune responses in the lung, Nanomedicine, 2014, 9, 12, 1857

    CrossRef

  23. 23
    W. David Wilson, Nicola Pusterla, Debra C. Long, Equine Infectious Diseases, 2014,

    CrossRef

  24. 24
    C. J. Phillips, T. Woolpert, C. Sevick, D. Faix, P. J. Blair, N. F. Crum-Cianflone, Comparison of the Effectiveness of Trivalent Inactivated Influenza Vaccine and Live, Attenuated Influenza Vaccine in Preventing Influenza-Like Illness Among US Military Service Members, 2006-2009, Clinical Infectious Diseases, 2013, 56, 1, 11

    CrossRef

  25. 25
    Iman Almansour, Huaiqing Chen, Shixia Wang, Shan Lu, Cross reactivity of serum antibody responses elicited by DNA vaccines expressing HA antigens from H1N1 subtype influenza vaccines in the past 30 years, Human Vaccines & Immunotherapeutics, 2013, 9, 10, 2049

    CrossRef

  26. 26
    Ramaiah Arunachalam, Detection of site-specific positive Darwinian selection on pandemic influenza A/H1N1 virus genome: integrative approaches, Genetica, 2013, 141, 4-6, 143

    CrossRef

  27. 27
    José González-Valdez, José Manuel Aguilar-Yáñez, Jorge Benavides, Marco Rito-Palomares, DNA based vaccines offer improved vaccination supply for the developing world, Journal of Chemical Technology and Biotechnology, 2013, 88, 6
  28. 28
    A. Camacho, B. Cazelles, Does homologous reinfection drive multiple-wave influenza outbreaks? Accounting for immunodynamics in epidemiological models, Epidemics, 2013, 5, 4, 187

    CrossRef

  29. 29
    Janet E McElhaney, Rhea N Coler, Susan L Baldwin, Immunologic correlates of protection and potential role for adjuvants to improve influenza vaccines in older adults, Expert Review of Vaccines, 2013, 12, 7, 759

    CrossRef

  30. 30
    N. Jiang, J. He, J. A. Weinstein, L. Penland, S. Sasaki, X.-S. He, C. L. Dekker, N.-Y. Zheng, M. Huang, M. Sullivan, P. C. Wilson, H. B. Greenberg, M. M. Davis, D. S. Fisher, S. R. Quake, Lineage Structure of the Human Antibody Repertoire in Response to Influenza Vaccination, Science Translational Medicine, 2013, 5, 171, 171ra19

    CrossRef

  31. 31
    M. I. Barria, J. L. Garrido, C. Stein, E. Scher, Y. Ge, S. M. Engel, T. A. Kraus, D. Banach, T. M. Moran, Localized Mucosal Response to Intranasal Live Attenuated Influenza Vaccine in Adults, Journal of Infectious Diseases, 2013, 207, 1, 115

    CrossRef

  32. 32
    Senthil Murugappan, Harshad P. Patil, Gaurav Kanojia, Wouter ter Veer, Tjarko Meijerhof, Henderik W. Frijlink, Anke Huckriede, Wouter L.J. Hinrichs, Physical and immunogenic stability of spray freeze-dried influenza vaccine powder for pulmonary delivery: Comparison of inulin, dextran, or a mixture of dextran and trehalose as protectants, European Journal of Pharmaceutics and Biopharmaceutics, 2013, 85, 3, 716

    CrossRef

  33. 33
    Babak Jalilian, Stig Hill Christiansen, Halldór Bjarki Einarsson, Mehdi Rasoli Pirozyan, Eskild Petersen, Thomas Vorup-Jensen, Properties and prospects of adjuvants in influenza vaccination - messy precipitates or blessed opportunities?, Molecular and Cellular Therapies, 2013, 1, 1, 2

    CrossRef

  34. 34
    Tatiana Bousse, David A. Shore, Cynthia S. Goldsmith, M. Jaber Hossain, Yunho Jang, Charles T. Davis, Ruben O. Donis, James Stevens, Quantitation of influenza virus using field flow fractionation and multi-angle light scattering for quantifying influenza A particles, Journal of Virological Methods, 2013, 193, 2, 589

    CrossRef

  35. 35
    Benjaluck Phonrat, Punnee Pitisuttithum, Supat Chamnanchanunt, Pilaipan Puthavathana, Nathamon Ngaosuwankul, Suda Louisirirotchanakul, Jittima Dhitavat, Sit Thirapakpoomanunt, Vichai Chokevivat, Suwit Wibulpolprasert, Safety and immune responses following administration of H1N1 live attenuated influenza vaccine in Thais, Vaccine, 2013, 31, 11, 1503

    CrossRef

  36. 36
    Matt A. Burchill, Beth A. Tamburini, Nathan D. Pennock, Jason T. White, Jonathan S. Kurche, Ross M. Kedl, T cell vaccinology: Exploring the known unknowns, Vaccine, 2013, 31, 2, 297

    CrossRef

  37. 37
    Svetlana Shcherbik, Sheila B. Sergent, William G. Davis, Bo Shu, John Barnes, Alexander Klimov, Tatiana Bousse, WITHDRAWN: Application of real time RT-PCR for the genetic homogeneity and stability tests of the seed candidates for live attenuated influenza vaccine production, Journal of Virological Methods, 2013,

    CrossRef

  38. 38
    Hiroaki Katsura, Kiyoko Iwatsuki-Horimoto, Satoshi Fukuyama, Shinji Watanabe, Saori Sakabe, Yasuko Hatta, Shin Murakami, Masayuki Shimojima, Taisuke Horimoto, Yoshihiro Kawaoka, A replication-incompetent virus possessing an uncleavable hemagglutinin as an influenza vaccine, Vaccine, 2012, 30, 42, 6027

    CrossRef

  39. 39
    Laura E. Richert, Amy E. Servid, Ann L. Harmsen, Agnieszka Rynda-Apple, Soo Han, James A. Wiley, Trevor Douglas, Allen G. Harmsen, A virus-like particle vaccine platform elicits heightened and hastened local lung mucosal antibody production after a single dose, Vaccine, 2012, 30, 24, 3653

    CrossRef

  40. 40
    Denise C. Hunter, Margot A. Skinner, Frances M. Wolber, Chris L. Booth, Jacelyn M. S. Loh, Mark Wohlers, Lesley M. Stevenson, Marlena C. Kruger, Consumption of gold kiwifruit reduces severity and duration of selected upper respiratory tract infection symptoms and increases plasma vitamin C concentration in healthy older adults, British Journal of Nutrition, 2012, 108, 07, 1235

    CrossRef

  41. 41
    Jonathan A. McCullers, Victor C. Huber, Correlates of vaccine protection from influenza and its complications, Human Vaccines & Immunotherapeutics, 2012, 8, 1, 34

    CrossRef

  42. 42
    Amritha Ramakrishnan, Keri N. Althoff, Joseph A. Lopez, Christian L. Coles, Jay H. Bream, Differential serum cytokine responses to inactivated and live attenuated seasonal influenza vaccines, Cytokine, 2012, 60, 3, 661

    CrossRef

  43. 43
    Huiling Wei, Stephen D. Lenz, David H. Thompson, Roman M. Pogranichniy, DNA-Vaccine Platform Development Against H1N1 Subtype of Swine Influenza A Viruses, Viral Immunology, 2012, 25, 4, 297

    CrossRef

  44. 44
    B. J. Cowling, Editorial Commentary: Airborne Transmission of Influenza: Implications for Control in Healthcare and Community Settings, Clinical Infectious Diseases, 2012, 54, 11, 1578

    CrossRef

  45. 45
    Kevin Yim, Brian Miles, Rachel Zinsou, Gregory Prince, Marina Boukhvalova, Efficacy of trivalent inactivated influenza vaccines in the cotton rat Sigmodon hispidus model, Vaccine, 2012, 30, 7, 1291

    CrossRef

  46. 46
    Bin Zhou, Yan Li, Scott D. Speer, Anju Subba, Xudong Lin, David E. Wentworth, Engineering temperature sensitive live attenuated influenza vaccines from emerging viruses, Vaccine, 2012, 30, 24, 3691

    CrossRef

  47. 47
    Giuliano Rizzardini, Dorte Eskesen, Philip C. Calder, Amedeo Capetti, Lillian Jespersen, Mario Clerici, Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431® in an influenza vaccination model: a randomised, double-blind, placebo-controlled study, British Journal of Nutrition, 2012, 107, 06, 876

    CrossRef

  48. 48
    Carolien E. van de Sandt, Joost H. C. M. Kreijtz, Guus F. Rimmelzwaan, Evasion of Influenza A Viruses from Innate and Adaptive Immune Responses, Viruses, 2012, 4, 12, 1438

    CrossRef

  49. 49
    Tina-Marie Assi, Korngamon Rookkapan, Jayant Rajgopal, Vorasith Sornsrivichai, Shawn T. Brown, Joel S. Welling, Bryan A. Norman, Diana L. Connor, Sheng-I Chen, Rachel B. Slayton, Yongjua Laosiritaworn, Angela R. Wateska, Stephen R. Wisniewski, Bruce Y. Lee, How influenza vaccination policy may affect vaccine logistics, Vaccine, 2012, 30, 30, 4517

    CrossRef

  50. 50
    Stan L. Block, Judith Falloon, Jeffrey A. Hirschfield, Leonard R. Krilov, Filip Dubovsky, Tingting Yi, Robert B. Belshe, Immunogenicity and Safety of a Quadrivalent Live Attenuated Influenza Vaccine in Children, The Pediatric Infectious Disease Journal, 2012, 31, 7, 745

    CrossRef

  51. 51
    Seyyed Mahmoud Ebrahimi, Mehran Dabaghian, Majid Tebianian, Mohammad Hossein Zabeh Jazi, In contrast to conventional inactivated influenza vaccines, 4xM2e.HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza A isolates circulating in Iran, Virology, 2012, 430, 1, 63

    CrossRef

  52. 52
    André Ballesteros-Tato, Beatriz León, Beth A. Graf, Amy Moquin, Pamela Scott Adams, Frances E. Lund, Troy D. Randall, Interleukin-2 Inhibits Germinal Center Formation by Limiting T Follicular Helper Cell Differentiation, Immunity, 2012, 36, 5, 847

    CrossRef

  53. 53
    Seol Hee Hong, Young-Ho Byun, Chung Truong Nguyen, Soo Young Kim, Baik Lin Seong, Songyong Park, Gyu-Jin Woo, Yeup Yoon, Jeong Tae Koh, Kohtaro Fujihashi, Joon Haeng Rhee, Shee Eun Lee, Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection, Vaccine, 2012, 30, 2, 466

    CrossRef

  54. 54
    Xueliang Wang, Wenjie Zhang, Fen Liu, Mei Zheng, Dan Zheng, Tao Zhang, Yinglei Yi, Yahong Ding, Jian Luo, Chaoyang Dai, Hanzhong Wang, Bing Sun, Ze Chen, Intranasal immunization with live attenuated influenza vaccine plus chitosan as an adjuvant protects mice against homologous and heterologous virus challenge, Archives of Virology, 2012, 157, 8, 1451

    CrossRef

  55. 55
    Manki Song, Huynh A. Hong, Jen-Min Huang, Claire Colenutt, Dinh Duy Khang, Thi Van Anh Nguyen, Sung-Moo Park, Byoung-Shik Shim, Ho Hyun Song, In Su Cheon, Ji Eun Jang, Jung-ah Choi, Young Ki Choi, Konrad Stadler, Simon M. Cutting, Killed Bacillus subtilis spores as a mucosal adjuvant for an H5N1 vaccine, Vaccine, 2012, 30, 22, 3266

    CrossRef

  56. 56
    Markus A Rose, Stefan Zielen, Ulrich Baumann, Mucosal immunity and nasal influenza vaccination, Expert Review of Vaccines, 2012, 11, 5, 595

    CrossRef

  57. 57
    Gourapura J. Renukaradhya, Varun Dwivedi, Cordelia Manickam, Basavaraj Binjawadagi, David Benfield, Mucosal vaccines to prevent porcine reproductive and respiratory syndrome: a new perspective, Animal Health Research Reviews, 2012, 13, 01, 21

    CrossRef

  58. 58
    Jennifer Humberd Smith, Mark Papania, Darin Knaus, Paula Brooks, Debra L. Haas, Raydel Mair, James Barry, S. Mark Tompkins, Ralph A. Tripp, Nebulized live-attenuated influenza vaccine provides protection in ferrets at a reduced dose, Vaccine, 2012, 30, 19, 3026

    CrossRef

  59. 59
    Vincent Pavot, Nicolas Rochereau, Christian Genin, Bernard Verrier, Stéphane Paul, New insights in mucosal vaccine development, Vaccine, 2012, 30, 2, 142

    CrossRef

  60. 60
    Fu-Shi Quan, Richard W. Compans, Sang-Moo Kang, Oral vaccination with inactivated influenza vaccine induces cross-protective immunity, Vaccine, 2012, 30, 2, 180

    CrossRef

  61. 61
    Jianzhong Shi, Zhiyuan Wen, Jing Guo, Ying Zhang, Guohua Deng, Yuelong Shu, Dayan Wang, Yongping Jiang, Yoshihiro Kawaoka, Zhigao Bu, Hualan Chen, Protective efficacy of an H1N1 cold-adapted live vaccine against the 2009 pandemic H1N1, seasonal H1N1, and H5N1 influenza viruses in mice, Antiviral Research, 2012, 93, 3, 346

    CrossRef

  62. 62
    C.R. Wells, C.T. Bauch, The impact of personal experiences with infection and vaccination on behaviour–incidence dynamics of seasonal influenza, Epidemics, 2012, 4, 3, 139

    CrossRef

  63. 63
    Debby van Riel, Thijs Kuiken, The role of cell tropism for the pathogenesis of influenza in humans, Future Virology, 2012, 7, 3, 295

    CrossRef

  64. 64
    Christopher S. Ambrose, Xionghua Wu, Taff Jones, Raburn M. Mallory, The role of nasal IgA in children vaccinated with live attenuated influenza vaccine, Vaccine, 2012, 30, 48, 6794

    CrossRef

  65. 65
    Qi Chen, Darin Madson, Cathy L. Miller, D.L. Hank Harris, Vaccine development for protecting swine against influenza virus, Animal Health Research Reviews, 2012, 13, 02, 181

    CrossRef

  66. 66
    Stan L. Block, Tingting Yi, Eric Sheldon, Filip Dubovsky, Judith Falloon, A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults, Vaccine, 2011, 29, 50, 9391

    CrossRef

  67. 67
    K. M. Gustin, T. R. Maines, J. A. Belser, N. van Hoeven, X. Lu, L. Dong, I. Isakova-Sivak, L.-M. Chen, J. T. M. Voeten, J. G. M. Heldens, H. van den Bosch, N. J. Cox, T. M. Tumpey, A. I. Klimov, L. Rudenko, R. O. Donis, J. M. Katz, Comparative Immunogenicity and Cross-Clade Protective Efficacy of Mammalian Cell-Grown Inactivated and Live Attenuated H5N1 Reassortant Vaccines in Ferrets, Journal of Infectious Diseases, 2011, 204, 10, 1491

    CrossRef

  68. 68
    Afton L. Thompson, Herman F. Staats, Cytokines: The Future of Intranasal Vaccine Adjuvants, Clinical and Developmental Immunology, 2011, 2011, 1

    CrossRef

  69. 69
    Ok-Ran Lee, Gayathri Sathiyaraj, Yu-Jin Kim, Jun-Gyo In, Woo-Seang Kwon, Ju-Han Kim, Deok-Chun Yang, Defense Genes Induced by Pathogens and Abiotic Stresses in Panax ginseng C.A. Meyer, Journal of Ginseng Research, 2011, 35, 1, 1

    CrossRef

  70. 70
    Nand Kishore Gupta, Priti Tomar, Vikas Sharma, Vinod Kumar Dixit, Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza, Vaccine, 2011, 29, 48, 9026

    CrossRef

  71. 71
    Jin-Young Kim, Hyoung-Jin Kim, Hong-Jin Kim, Effect of Oral Administration of Korean Red Ginseng on Influenza A (H1N1) Virus Infection, Journal of Ginseng Research, 2011, 35, 1, 104

    CrossRef

  72. 72
    Shira C Shafir, Kaitlin A O'Keefe, Kimberley I Shoaf, Evaluation of the seroprevalence of influenza A(H1N1) 2009 on a university campus: a cross-sectional study, BMC Public Health, 2011, 11, 1, 922

    CrossRef

  73. 73
    A. Camacho, S. Ballesteros, A. L. Graham, F. Carrat, O. Ratmann, B. Cazelles, Explaining rapid reinfections in multiple-wave influenza outbreaks: Tristan da Cunha 1971 epidemic as a case study, Proceedings of the Royal Society B: Biological Sciences, 2011, 278, 1725, 3635

    CrossRef

  74. 74
    Irina Isakova-Sivak, Li-Mei Chen, Yumiko Matsuoka, J. Theo M. Voeten, Irina Kiseleva, Jacco G.M. Heldens, Han van den Bosch, Alexander Klimov, Larisa Rudenko, Nancy J. Cox, Ruben O. Donis, Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2), Virology, 2011, 412, 2, 297

    CrossRef

  75. 75
    Astrid Lauscher, Bjørn Krossøy, Petter Frost, Søren Grove, Melanie König, Jon Bohlin, Knut Falk, Lars Austbø, Espen Rimstad, Immune responses in Atlantic salmon (Salmo salar) following protective vaccination against Infectious salmon anemia (ISA) and subsequent ISA virus infection, Vaccine, 2011, 29, 37, 6392

    CrossRef

  76. 76
    Janet E. McElhaney, Influenza vaccine responses in older adults, Ageing Research Reviews, 2011, 10, 3, 379

    CrossRef

  77. 77
    Katie Harris, Rebecca Ream, Jin Gao, Maryna C Eichelberger, Intramuscular immunization of mice with live influenza virus is more immunogenic and offers greater protection than immunization with inactivated virus, Virology Journal, 2011, 8, 1, 251

    CrossRef

  78. 78
    Varun Dwivedi, Cordelia Manickam, Ruthi Patterson, Katie Dodson, Matthew Weeman, Gourapura J. Renukaradhya, Intranasal delivery of whole cell lysate of Mycobacterium tuberculosis induces protective immune responses to a modified live porcine reproductive and respiratory syndrome virus vaccine in pigs, Vaccine, 2011, 29, 23, 4067

    CrossRef

  79. 79
    Sanae Sasaki, Meghan Sullivan, Carlos F. Narvaez, Tyson H. Holmes, David Furman, Nai-Ying Zheng, Madhuri Nishtala, Jens Wrammert, Kenneth Smith, Judith A. James, Cornelia L. Dekker, Mark M. Davis, Patrick C. Wilson, Harry B. Greenberg, Xiao-Song He, Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies, Journal of Clinical Investigation, 2011, 121, 8, 3109

    CrossRef

  80. 80
    Irene Salinas, Yong-An Zhang, J. Oriol Sunyer, Mucosal immunoglobulins and B cells of teleost fish, Developmental & Comparative Immunology, 2011, 35, 12, 1346

    CrossRef

  81. 81
    Xiao-Song He, Sanae Sasaki, Carlos F. Narvaez, Caiqiu Zhang, Hui Liu, Jennifer C. Woo, George W. Kemble, Cornelia L. Dekker, Mark M. Davis, Harry B. Greenberg, Plasmablast-derived polyclonal antibody response after influenza vaccination, Journal of Immunological Methods, 2011, 365, 1-2, 67

    CrossRef

  82. 82
    Yue-Qiang DUAN, De-Yan LUO, Li XING, Peng-Hui YANG, Zhong-Peng ZHAO, Wei-Hong JIA, Pei-Feng LI, Xi-Liang WANG, Rescue and Immunogenic Evaluation of Attenuated Vaccine Candidate From A/California/07/2009, PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2011, 37, 12, 1289

    CrossRef

  83. 83
    Mark S. Riddle, Robert W. Kaminski, Carlos Williams, Chad Porter, Shahida Baqar, Alexis Kordis, Theron Gilliland, Joyce Lapa, Melissa Coughlin, Chris Soltis, Erica Jones, Jackie Saunders, Paul B. Keiser, Ryan T. Ranallo, Robert Gormley, Michael Nelson, K. Ross Turbyfill, David Tribble, Edwin V. Oaks, Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine, Vaccine, 2011, 29, 40, 7009

    CrossRef

  84. 84
    Nicole D. Powell, Rebecca G. Allen, Amy R. Hufnagle, John F. Sheridan, Michael T. Bailey, Stressor-Induced Alterations of Adaptive Immunity to Vaccination and Viral Pathogens, Immunology and Allergy Clinics of North America, 2011, 31, 1, 69

    CrossRef

  85. You have full text access to this Open Access content85
    Christopher S. Ambrose, Myron J. Levin, Robert B. Belshe, The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults, Influenza and Other Respiratory Viruses, 2011, 5, 2
  86. 86
    Nora C. Toussaint, Yaakov Maman, Oliver Kohlbacher, Yoram Louzoun, Universal peptide vaccines – Optimal peptide vaccine design based on viral sequence conservation, Vaccine, 2011, 29, 47, 8745

    CrossRef

  87. 87
    Juine-Ruey Chen, Che Ma, Chi-Huey Wong, Vaccine design of hemagglutinin glycoprotein against influenza, Trends in Biotechnology, 2011, 29, 9, 426

    CrossRef

  88. 88
    Jeremy C. Jones, Erik W. Settles, Curtis R. Brandt, Stacey Schultz-Cherry, Virus aggregating peptide enhances the cell-mediated response to influenza virus vaccine, Vaccine, 2011, 29, 44, 7696

    CrossRef

  89. 89
    William M. Gwinn, Shaun M. Kirwan, Sheena H. Wang, Kathleen A. Ashcraft, Neil L. Sparks, Catherine R. Doil, Tom G. Tlusty, Leslie S. Casey, Susan K. Hollingshead, David E. Briles, Richard S. Dondero, Anthony J. Hickey, W. Michael Foster, Herman F. Staats, Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1, Vaccine, 2010, 28, 42, 6901

    CrossRef

  90. 90
    Yeu-Chun Kim, Fu-Shi Quan, Richard W. Compans, Sang-Moo Kang, Mark R. Prausnitz, Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity, Journal of Controlled Release, 2010, 142, 2, 187

    CrossRef

  91. 91
    V. Saluja, M.R. Visser, M.L. van Roosmalen, K. Leenhouts, A. Huckriede, W.L.J. Hinrichs, H.W. Frijlink, Gastro-intestinal delivery of influenza subunit vaccine formulation adjuvanted with Gram-positive enhancer matrix (GEM) particles, European Journal of Pharmaceutics and Biopharmaceutics, 2010, 76, 3, 470

    CrossRef

  92. 92
    Eun-Young Lee, Kwang-Hee Lee, Eun-Ju Jung, Yo Han Jang, Sang-Uk Seo, Hyun-Ah Kim, Baik Lin Seong, Genotyping and screening of reassortant live-attenuated influenza B vaccine strain, Journal of Virological Methods, 2010, 165, 2, 133

    CrossRef

  93. 93
    E. William St.Clair, Good and bad memories following rituximab therapy, Arthritis & Rheumatism, 2010, 62, 1
  94. 94
    Zichria Zakay-Rones, Human influenza vaccines and assessment of immunogenicity, Expert Review of Vaccines, 2010, 9, 12, 1423

    CrossRef

  95. 95
    Aleksandar Masic, Xinya Lu, Junwei Li, George K. Mutwiri, Lorne A. Babiuk, Earl G. Brown, Yan Zhou, Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs, Vaccine, 2010, 28, 43, 7098

    CrossRef

  96. 96
    Orli Even-Or, Sarit Samira, Eli Rochlin, Shobana Balasingam, Alex J. Mann, Rob Lambkin-Williams, Jack Spira, Itzhak Goldwaser, Ronald Ellis, Yechezkel Barenholz, Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccine, Vaccine, 2010, 28, 39, 6527

    CrossRef

  97. 97
    V. Saluja, M.R. Visser, W. ter Veer, M.L. van Roosmalen, K. Leenhouts, W.L.J. Hinrichs, A. Huckriede, H.W. Frijlink, Influenza antigen-sparing by immune stimulation with Gram-positive enhancer matrix (GEM) particles, Vaccine, 2010, 28, 50, 7963

    CrossRef

  98. 98
    Vinay Saluja, Jean P. Amorij, Maarten L. van Roosmalen, Kees Leenhouts, Anke Huckriede, Wouter L. J. Hinrichs, Henderik W. Frijlink, Intranasal Delivery of Influenza Subunit Vaccine Formulated with GEM Particles as an Adjuvant, The AAPS Journal, 2010, 12, 2, 109

    CrossRef

  99. 99
    Jean-Pierre Amorij, Wouter LJ Hinrichs, Henderik W Frijlink, Jan C Wilschut, Anke Huckriede, Needle-free influenza vaccination, The Lancet Infectious Diseases, 2010, 10, 10, 699

    CrossRef

  100. 100
    Jessica L. Halliley, Shuya Kyu, James J. Kobie, Edward E. Walsh, Ann R. Falsey, Troy D. Randall, John Treanor, Changyong Feng, Ignacio Sanz, F. Eun-Hyung Lee, Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization, Vaccine, 2010, 28, 20, 3582

    CrossRef

  101. 101
    Hye Mee Joo, Yuxia He, Aarthi Sundararajan, Lifang Huan, Mark Y. Sangster, Quantitative analysis of influenza virus-specific B cell memory generated by different routes of inactivated virus vaccination, Vaccine, 2010, 28, 10, 2186

    CrossRef

  102. 102
    Eun-Ju Jung, Kwang-Hee Lee, Baik Lin Seong, Reverse genetic platform for inactivated and live-attenuated influenza vaccine, Experimental and Molecular Medicine, 2010, 42, 2, 116

    CrossRef

  103. 103
    Mookkan Prabakaran, Selvaraj Madhan, Nayana Prabhu, Grace Yuhong Geng, Roger New, Jimmy Kwang, Reverse micelle-encapsulated recombinant baculovirus as an oral vaccine against H5N1 infection in mice, Antiviral Research, 2010, 86, 2, 180

    CrossRef

  104. 104
    Wenjun Ma, Jürgen A. Richt, Swine influenza vaccines: current status and future perspectives, Animal Health Research Reviews, 2010, 11, 01, 81

    CrossRef

  105. 105
    William A. Langley, Konrad C. Bradley, Zhu-Nan Li, Ganesh R. Talekar, Summer E. Galloway, David A. Steinhauer, The effects of preexisting immunity to influenza on responses to influenza vectors in mice, Vaccine, 2010, 28, 38, 6305

    CrossRef

  106. 106
    Stacey Schultz-Cherry, Jeremy C. Jones, 2010,

    CrossRef

  107. You have full text access to this Open Access content107
    Arnt-Ove Hovden, Karl A. Brokstad, Diane Major, John Wood, Lars R. Haaheim, Rebecca J. Cox, A pilot study of the immune response to whole inactivated avian influenza H7N1 virus vaccine in mice, Influenza and Other Respiratory Viruses, 2009, 3, 1
  108. 108
    Marla Lay, Bernadette Callejo, Stella Chang, David K. Hong, David B. Lewis, Timothy D. Carroll, Shannon Matzinger, Linda Fritts, Christopher J. Miller, John F. Warner, Lily Liang, Jeffery Fairman, Cationic lipid/DNA complexes (JVRS-100) combined with influenza vaccine (Fluzone®) increases antibody response, cellular immunity, and antigenically drifted protection, Vaccine, 2009, 27, 29, 3811

    CrossRef

  109. 109
    Nina Wressnigg, Daniel Voss, Thorsten Wolff, Julia Romanova, Tanja Ruthsatz, Ines Mayerhofer, Manfred Reiter, Sabine Nakowitsch, Johannes Humer, Alexander Morokutti, Thomas Muster, Andrej Egorov, Christian Kittel, Development of a live-attenuated influenza B ΔNS1 intranasal vaccine candidate, Vaccine, 2009, 27, 21, 2851

    CrossRef

  110. 110
    Junbao Yang, John A. Gebe, Laurie Huston, Eddie James, Venus Tan, Betty B. Yue, Gerald T. Nepom, William W. Kwok, H5N1 strain-specific Hemagglutinin CD4+ T cell epitopes restricted by HLA DR4, Vaccine, 2009, 27, 29, 3862

    CrossRef

  111. 111
    Mauricio Rodríguez-Álvarez, Ana María Velasco-Velasco, Nelson J. Álvarez-Anell, María Eugenia Jiménez-Corona, Samuel Ponce de León-Rosales, Identification of Seasonal Vaccine Hemagglutinin Subtype 1 (H1) Epitopes in Mexican Isolates of the New Influenza A (H1N1) 2009 Virus, Archives of Medical Research, 2009, 40, 8, 687

    CrossRef

  112. 112
    Zhiyuan Wen, Ling Ye, Yulong Gao, Lei Pan, Ke Dong, Zhigao Bu, Richard W. Compans, Chinglai Yang, Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge, Antiviral Research, 2009, 84, 3, 215

    CrossRef

  113. 113
    Michele Michael, Elizabeth Helm, Brigit Van Graafeiland, Frank Malinoski, Jay Bauman, Influenza Vaccination with a Live Attenuated Vaccine, AJN, American Journal of Nursing, 2009, 109, 10, 44

    CrossRef

  114. 114
    Yoshitaka Kashima, Mizuho Ikeda, Yasushi Itoh, Yoshihiro Sakoda, Tomoya Nagata, Taichiro Miyake, Kosuke Soda, Hiroichi Ozaki, Misako Nakayama, Hitomi Shibuya, Masatoshi Okamatsu, Hirohito Ishigaki, Hideaki Ishida, Toshihiro Sawai, Yoshihiro Kawaoka, Hiroshi Kida, Kazumasa Ogasawara, Intranasal administration of a live non-pathogenic avian H5N1 influenza virus from a virus library confers protective immunity against H5N1 highly pathogenic avian influenza virus infection in mice: Comparison of formulations and administration routes of vaccines, Vaccine, 2009, 27, 52, 7402

    CrossRef

  115. 115
    Yoshikazu Yuki, Hiroshi Kiyono, Mucosal vaccines: novel advances in technology and delivery, Expert Review of Vaccines, 2009, 8, 8, 1083

    CrossRef

  116. 116
    Lars R. Haaheim, Abdullah S. Madhun, Rebecca Cox, Pandemic Influenza Vaccines – The Challenges, Viruses, 2009, 1, 3, 1089

    CrossRef

  117. 117
    A. Masic, L. A. Babiuk, Y. Zhou, Reverse genetics-generated elastase-dependent swine influenza viruses are attenuated in pigs, Journal of General Virology, 2009, 90, 2, 375

    CrossRef

  118. 118
    D. Coucke, M. Schotsaert, C. Libert, E. Pringels, C. Vervaet, P. Foreman, X. Saelens, J.P. Remon, Spray-dried powders of starch and crosslinked poly(acrylic acid) as carriers for nasal delivery of inactivated influenza vaccine, Vaccine, 2009, 27, 8, 1279

    CrossRef

  119. 119
    Manish Sinha, Swine flu, Journal of Infection and Public Health, 2009, 2, 4, 157

    CrossRef

  120. 120
    Karoline Droebner, Emanuel Haasbach, Cordula Fuchs, Andreas O. Weinzierl, Stefan Stevanovic, Mathias Büttner, Oliver Planz, Antibodies and CD4+ T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain, Vaccine, 2008, 26, 52, 6965

    CrossRef

  121. 121
    Sang-Uk Seo, Young-Ho Byun, Eun-Young Lee, Eun-Ju Jung, Yo Han Jang, Hyun-Ah Kim, Suk-Hoon Ha, Kwang-Hee Lee, Baik Lin Seong, Development and characterization of a live attenuated influenza B virus vaccine candidate, Vaccine, 2008, 26, 7, 874

    CrossRef

  122. 122
    J-P. Amorij, A. Huckriede, J. Wilschut, H. W. Frijlink, W. L. J. Hinrichs, Development of Stable Influenza Vaccine Powder Formulations: Challenges and Possibilities, Pharmaceutical Research, 2008, 25, 6, 1256

    CrossRef

  123. 123
    J. Williman, S. Young, G. Buchan, L. Slobbe, M. Wilson, P. Pang, J. Austyn, S. Preston, M. Baird, DNA fusion vaccines incorporating IL-23 or RANTES for use in immunization against influenza, Vaccine, 2008, 26, 40, 5153

    CrossRef

  124. 124
    Shixia Wang, Chris Parker, Jessica Taaffe, Alicia Solórzano, Adolfo García-Sastre, Shan Lu, Heterologous HA DNA vaccine prime—inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses, Vaccine, 2008, 26, 29-30, 3626

    CrossRef

  125. You have full text access to this Open Access content125
    Kylie Goy, Sally Von Bibra, Jenny Lewis, Karen Laurie, Ian Barr, David Anderson, Margaret Hellard, Rosemary Ffrench, Heterosubtypic T-cell responses against avian influenza H5 haemagglutinin are frequently detected in individuals vaccinated against or previously infected with human subtypes of influenza, Influenza and Other Respiratory Viruses, 2008, 2, 4
  126. 126
    Andrea Gambotto, Simon M Barratt-Boyes, Menno D de Jong, Gabriele Neumann, Yoshihiro Kawaoka, Human infection with highly pathogenic H5N1 influenza virus, The Lancet, 2008, 371, 9622, 1464

    CrossRef

  127. 127
    Gregory A. Poland, Inna G. Ovsyannikova, Robert M. Jacobson, Immunogenetics of seasonal influenza vaccine response, Vaccine, 2008, 26, D35

    CrossRef

  128. 128
    Janet E McElhaney, Influenza vaccination in the elderly: seeking new correlates of protection and improved vaccines, Aging Health, 2008, 4, 6, 603

    CrossRef

  129. 129
    Harunor Rashid, Shuja Shafi, Elizabeth Haworth, Ziad A. Memish, Haitham El Bashir, Kamal A. Ali, Robert Booy, Influenza vaccine in Hajj pilgrims: Policy issues from field studies, Vaccine, 2008, 26, 37, 4809

    CrossRef

  130. 130
    Martin Keech, Paul Beardsworth, The Impact of Influenza on Working Days Lost, PharmacoEconomics, 2008, 26, 11, 911

    CrossRef

  131. 131
    Karin Riedl, Rosemarie Riedl, Alexander von Gabain, Eszter Nagy, Karen Lingnau, The novel adjuvant IC31® strongly improves influenza vaccine-specific cellular and humoral immune responses in young adult and aged mice, Vaccine, 2008, 26, 27-28, 3461

    CrossRef

  132. 132
    David Scott McVey, Melissa Kennedy, Vaccines for Emerging and Re-Emerging Viral Diseases of Companion Animals, Veterinary Clinics of North America: Small Animal Practice, 2008, 38, 4, 903

    CrossRef

  133. 133
    Francis Davoine, Min Cao, Yingqi Wu, Farnam Ajamian, Ramses Ilarraza, Andy I. Kokaji, Redwan Moqbel, Darryl J. Adamko, Virus-induced eosinophil mediator release requires antigen-presenting and CD4+ T cells, Journal of Allergy and Clinical Immunology, 2008, 122, 1, 69

    CrossRef

  134. 134
    S. Hauge, A. S. Madhun, R. J. Cox, K. A. Brokstad, L. R. Haaheim, A Comparison of the Humoral and Cellular Immune Responses at Different Immunological Sites after Split Influenza Virus Vaccination of Mice, Scandinavian Journal of Immunology, 2007, 65, 1
  135. 135
    J. Reina, Consideraciones y estrategias vacunales frente a la gripe aviar H5N1, Vacunas, 2007, 8, 4, 23

    CrossRef

  136. You have full text access to this Open Access content136
    Katja Höschler, Robin Gopal, Nick Andrews, Melanie Saville, Stephanie Pepin, John Wood, Maria C. Zambon, Cross-neutralisation of antibodies elicited by an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine in healthy adults against H5N1 clade 2 strains, Influenza and Other Respiratory Viruses, 2007, 1, 5-6
  137. 137
    Huoying Shi, Xiu Fan Liu, Xiaorong Zhang, Sujuan Chen, Lei Sun, Jianhong Lu, Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses, Vaccine, 2007, 25, 42, 7379

    CrossRef

  138. 138
    Alenka M. Zeman, Tyson H. Holmes, Shaye Stamatis, Wenwei Tu, Xiao-Song He, Nancy Bouvier, George Kemble, Harry B. Greenberg, David B. Lewis, Ann M. Arvin, Cornelia L. Dekker, Humoral and Cellular Immune Responses in Children Given Annual Immunization With Trivalent Inactivated Influenza Vaccine, The Pediatric Infectious Disease Journal, 2007, 26, 2, 107

    CrossRef

  139. 139
    Sang-Uk Seo, Kwang-Hee Lee, Young-Ho Byun, Mi-Na Kweon, Baik Lin Seong, Immediate and broad-spectrum protection against heterologous and heterotypic lethal challenge in mice by live influenza vaccine, Vaccine, 2007, 25, 47, 8067

    CrossRef

  140. 140
    F. Denis, S. Hantz, S. Alain, Immunité et vaccinations antivirales : exemple de la muqueuse respiratoire, Antibiotiques, 2007, 9, 2, 130

    CrossRef

  141. 141
    Suresh P Vyas, Prem N Gupta, Implication of nanoparticles/microparticles in mucosal vaccine delivery, Expert Review of Vaccines, 2007, 6, 3, 401

    CrossRef

  142. 142
    Jeremy Jones, Curtis R Brandt, Stacey Schultz-Cherry, Influenza defense: expanding our arsenal with peptide antivirals, Future Virology, 2007, 2, 3, 231

    CrossRef

  143. 143
    A. Minne, J. Jaworska, K. Gerhold, B. Ahrens, A. Avagyan, R. Vanbever, P. M. Matricardi, A. C. Schmidt, E. Hamelmann, Intranasal delivery of whole influenza vaccine prevents subsequent allergen-induced sensitization and airway hyper-reactivity in mice, Clinical & Experimental Allergy, 2007, 37, 8
  144. You have full text access to this Open Access content144
    Jens-Christian Eriksson, Rebecca Jane Cox, Ewa Szyszko, Åke Davidsson, Karl Albert Brokstad, Local and systemic cytokine and chemokine responses after parenteral influenza vaccination, Influenza and Other Respiratory Viruses, 2007, 1, 4
  145. 145
    Bong-Su Kang, Hiroyuki Yahikozawa, Chang-Sung Koh, Byung S. Kim, Oral administration of live virus protects susceptible mice from developing Theiler's virus-induced demyelinating disease, Virology, 2007, 366, 1, 185

    CrossRef

  146. You have full text access to this Open Access content146
    Oleg P. Zhirnov, Elena I. Isaeva, Tatyana E. Konakova, Galini Thoidis, Lyudmila M. Piskareva, Irina I. Akopova, Alex Kartashov, Anatoly D. Altstein, Petr O. Ilyinskii, Alexander M. Shneider, Protection against mouse and avian influenza A strains via vaccination with a combination of conserved proteins NP, M1 and NS1, Influenza and Other Respiratory Viruses, 2007, 1, 2
  147. 147
    J-P. Amorij, V. Saluja, A.H. Petersen, W.L.J. Hinrichs, A. Huckriede, H.W. Frijlink, Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice, Vaccine, 2007, 25, 52, 8707

    CrossRef

  148. 148
    Antoine Minne, Jamila Louahed, Sybille Mehauden, Benoît Baras, Jean-Christophe Renauld, Rita Vanbever, The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response, Immunology, 2007, 122, 3
  149. You have full text access to this Open Access content149
    Lars R. Haaheim, Vaccines for an influenza pandemic: scientific and political challenges, Influenza and Other Respiratory Viruses, 2007, 1, 2
  150. 150
    W. David Wilson, Nicola Pusterla, Equine Infectious Diseases, 2007,

    CrossRef

  151. 151
    Paul G. Thomas, Rachael Keating, Diane J. Hulse-Post, Peter C. Doherty, Cell-mediated Protection in Influenza Infection, Emerging Infectious Diseases, 2006, 12, 1, 48

    CrossRef

  152. 152
    G W Rose, C L Cooper, Fluarix™, inactivated split-virus influenza vaccine, Expert Opinion on Biological Therapy, 2006, 6, 3, 301

    CrossRef

  153. 153
    C. M. Mittelholzer, K. A. Brokstad, K. Pauksens, R. Jonsson, M. Brytting, A. Linde, Human Cell Lines Used in a Micro Neutralization Test for Measuring Influenza-Neutralizing Antibodies, Scandinavian Journal of Immunology, 2006, 63, 4
  154. 154
    Masaki Uchida, Hideshi Natsume, Tohru Kishino, Toshinobu Seki, Masahiko Ogihara, Kazuhiko Juni, Masayuki Kimura, Yasunori Morimoto, Immunization by particle bombardment of antigen-loaded poly-(dl-lactide-co-glycolide) microspheres in mice, Vaccine, 2006, 24, 12, 2120

    CrossRef

  155. 155
    E. Szyszko, K. Brokstad, R. J. Cox, A.-O. Hovden, A. Madhun, L. R. Haaheim, Impact of Influenza Vaccine Formulation with a Detailed Analysis of the Cytokine Response, Scandinavian Journal of Immunology, 2006, 64, 5
  156. 156
    Christopher S. Ambrose, Robert E. Walker, Edward M. Connor, Live Attenuated Influenza Vaccine in Children, Seminars in Pediatric Infectious Diseases, 2006, 17, 4, 206

    CrossRef

  157. 157
    H. Bakke, H. H. Samdal, J. Holst, F. Oftung, I. L. Haugen, A.-C. Kristoffersen, A. Haugan, L. Janakova, G. E. Korsvold, G. Krogh, E. A. S. Andersen, P. Djupesland, T. Holand, R. Rappuoli, B. Haneberg, Oral Spray Immunization May Be an Alternative to Intranasal Vaccine Delivery to Induce Systemic Antibodies but not Nasal Mucosal or Cellular Immunity, Scandinavian Journal of Immunology, 2006, 63, 3
  158. 158
    Rebecca J Cox, Karl A Brokstad, Lars R Haaheim, Pandemic influenza vaccine development: time is of the essence, Expert Review of Vaccines, 2006, 5, 5, 603

    CrossRef

  159. 159
    Rebecca Jane Cox, Lars Reinhardt Haaheim, Jens-Christian Ericsson, Abdullah Sami Madhun, Karl Albert Brokstad, The humoral and cellular responses induced locally and systemically after parenteral influenza vaccination in man, Vaccine, 2006, 24, 44-46, 6577

    CrossRef

  160. 160
    M.A. Stukova, S. Sereinig, N.V. Zabolotnyh, B. Ferko, C. Kittel, J. Romanova, T.I. Vinogradova, H. Katinger, O.I. Kiselev, A. Egorov, Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein, Tuberculosis, 2006, 86, 3-4, 236

    CrossRef

  161. 161
    Monique M. van Oers, Insect Viruses: Biotechnological Applications, 2006,

    CrossRef

  162. 162
    G. Bižanov, L. Janakova, S.-E. Knapstad, T. Karlstad, H. Bakke, I. L. Haugen, A. Haugan, H. H. Samdal, B. Haneberg, Immunoglobulin-A antibodies in Upper Airway Secretions may Inhibit Intranasal Influenza Virus Replication in Mice but not Protect Against Clinical Illness, Scandinavian Journal of Immunology, 2005, 61, 6
  163. 163
    Å. Davidsson, J.C. Eriksson, S. Rudblad, K. A. Brokstad, Influenza Specific Serum IgE is Present in Non-Allergic Subjects, Scandinavian Journal of Immunology, 2005, 62, 6
  164. 164
    Janet E McElhaney, Kristin L Nichol, Influenza vaccines: crossing the translational gap to improve outcomes in the elderly, Aging Health, 2005, 1, 1, 167

    CrossRef

  165. 165
    Jan Holmgren, Cecil Czerkinsky, Mucosal immunity and vaccines, Nature Medicine, 2005, 11, 4s, S45

    CrossRef

  166. 166
    Aase B. Mikalsen, Hilde Sindre, Jacob Torgersen, Espen Rimstad, Protective effects of a DNA vaccine expressing the infectious salmon anemia virus hemagglutinin-esterase in Atlantic salmon, Vaccine, 2005, 23, 41, 4895

    CrossRef

  167. 167
    A.-O. Hovden, R. J. Cox, A. Madhun, L. R. Haaheim, Two Doses of Parenterally Administered Split Influenza Virus Vaccine Elicited High Serum IgG Concentrations which Effectively Limited Viral Shedding upon Challenge in Mice, Scandinavian Journal of Immunology, 2005, 62, 4
  168. 168
    F. Denis, S. Alain, S. Hantz, P. Lagrange, Vaccination antivirale et immunité muqueuse respiratoire, La Presse Médicale, 2005, 34, 17, 1245

    CrossRef

  169. 169
    Iain Stephenson, Karl G Nicholson, John M Wood, Maria C Zambon, Jacqueline M Katz, Confronting the avian influenza threat: vaccine development for a potential pandemic, The Lancet Infectious Diseases, 2004, 4, 8, 499

    CrossRef

  170. 170
    Adeyemi Lawal, Chris Basler, Andrea Branch, Julio Gutierrez, Myron Schwartz, Thomas D. Schiano, Influenza Vaccination in Orthotopic Liver Transplant Recipients: Absence of Post Administration ALT Elevation, American Journal of Transplantation, 2004, 4, 11
  171. 171
    Abdullah Madhun, Rebecca Cox, Lars R Haaheim, Roland Jonsson, Karl Albert Brokstad, The kinetics of the systemic and local immune response to parenteral influenza vaccination, International Congress Series, 2004, 1263, 515

    CrossRef

  172. 172
    Bernd Kalbfuss-Zimmermann, Udo Reichl, Viral Vaccines Purification,